Clinical Trials
All Clinical Trials - Page 44 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT02653391Phase 1/Phase 2Completed
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for the Treatment of Fuchs' Corneal Endothelial Dystrophy (FCED)
Elamipretide
- NCT02138591Phase 3Withdrawn
Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.
Ll-37
- NCT02673632N/AUnknown
The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS
Gonadorelin
- NCT02681536N/AUnknown
Miniflare Versus Long Protocol in Poor Responders
Gonadorelin
- NCT02655770Phase 4Completed
Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
Liraglutide
- NCT02685852Phase 1Completed
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
Exenatide
- NCT02847403Phase 3Unknown
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
Exenatide
- NCT02673931N/AUnknown
GLP-1 and Hyperoxia for Organ Protection in Heart Surgery
Exenatide
- NCT02745470N/ACompleted
Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
Lixisenatide
- NCT02685709Phase 3Completed
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Octreotide
- NCT02631616Phase 1Unknown
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATET
Octreotide
- NCT02501161Phase 3Completed
A 104 Week Clinical Trial Comparing Long Term Glycaemic Control of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine Therapy in Subjects With Type 2 Diabetes Mellitus
Liraglutide
- NCT02533453Phase 4Completed
A 12/24-weeks, Open, Multi-centre, Phase IV Study on Safety and Efficacy of 2mg Exenatide Once Weekly (Bydureon) in T2DM Patients.
Exenatide
- NCT02648204Phase 3Completed
Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.
Semaglutide
- NCT06133946N/AActive Not Recruiting
Cohort Of DEafness-gene Screening
MOTS-c
- NCT02621736N/ACompleted
Copeptin for Prediction of Treatment Response in Children With Monosymptomatic Nocturnal Enuresis (MEN).
Desmopressin
- NCT02545751Phase 2Unknown
SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer
Thymosin-Alpha-1
- NCT02542930Phase 2Withdrawn
Abscopal Effect for Metastatic Non-small Cell Lung Cancer.
Thymosin-Alpha-1
- NCT02832999Phase 4Completed
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
Liraglutide
- NCT02650596N/AUnknown
Effects of GLP-1 on Chronic Heart Failure
Liraglutide
- NCT02650479Phase 1Completed
Study of the Effects of Intravenous Exenatide on Cardiac Repolarization
Exenatide
- NCT02597777N/ACompleted
Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin
Argireline
- NCT02698384N/ATerminated
Therapeutic Strategies in Acromegalic Subjects Treated With Lanreotide 120mg
Lanreotide
- NCT02647944Phase 2Completed
Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
Liraglutide
- NCT02651987Phase 2Completed
Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg
Lanreotide
- NCT02678520Phase 2Withdrawn
Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients
Gonadorelin
- NCT02588404N/AWithdrawn
The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient
Gonadorelin
- NCT02611232Phase 2Unknown
Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults
Liraglutide
- NCT02638805Phase 3Completed
Study of the Safety and Tolerability of Switching to ITCA 650 in Patients With Type 2 Diabetes Receiving Liraglutide
Liraglutide
- NCT02496611Phase 2Completed
Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity
Exenatide
- NCT02641899Phase 1Completed
Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs
Exenatide
- NCT02621489Phase 4Completed
Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
Exenatide
- NCT02641990Phase 1Completed
Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects
Exenatide
- NCT02656810Phase 1Completed
A Comparison Study of PF708 and Forteo in Healthy Subjects
Teriparatide
- NCT02431325Phase 2Completed
A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIV
Teduglutide
- NCT02730104N/ACompleted
Community-based Neuroendocrine Tumor (NET) Research Study
Lanreotide
- NCT02602600Phase 4Completed
Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
Liraglutide
- NCT02607306Phase 3Completed
A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Japanese Subjects With Type 2 Diabetes Mellitus.
Liraglutide
- NCT03889496N/ATerminated
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
Exenatide
- NCT02443155Phase 2Completed
A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
Liraglutide
- NCT02527200Phase 3Completed
Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome
Liraglutide
- NCT02559570Phase 2Completed
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
Linaclotide
- NCT03162042N/ACompleted
Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers
Follistatin
- NCT03534310N/ACompleted
Weight Loss With Intensive Lifestyle Modifications Plus Bariatric Surgery Versus Liraglutide 3 mg
Liraglutide
- NCT02559817Phase 2Terminated
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Linaclotide
- NCT02590432Phase 4Completed
An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Linaclotide
- NCT02615223N/AUnknown
Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
Gonadorelin
- NCT02357654Phase 4Recruiting
GnRH for Luteal Support in IVF/ICSI/FET Cycles
Gonadorelin
- NCT02617654Phase 2Completed
Liraglutide Effect on Beta-cell Function in C-peptide Positive Type 1 Diabetes
Liraglutide
- NCT03010683N/ACompleted
Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus
Liraglutide